• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ItalyChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
ACG 2025 | Stop Spinning Your Wheels on EoE
Gastroenterology
58 min
expert video

ACG 2025 | Stop Spinning Your Wheels on EoE

Diagnosing CSU: Hives, Angioedema, and Differential Diagnosis
Dermatology
2 min
expert video

Diagnosing CSU: Hives, Angioedema, and Differential Diagnosis

The Role of IL-4 and IL-13 in the Pathophysiology of CSU
Dermatology
2 min
expert video

The Role of IL-4 and IL-13 in the Pathophysiology of CSU

The Chronic Nature of CSU: Understanding Disease Duration and Persistence
Dermatology
1 min
expert video

The Chronic Nature of CSU: Understanding Disease Duration and Persistence

EAACI PAAM 2025 | How Type 2 Inflammation Shapes a Lifetime
Type 2 Inflammation
27 min
expert video

EAACI PAAM 2025 | How Type 2 Inflammation Shapes a Lifetime

UEG 2025 | Current and Emerging Treatment Options in EoE
Gastroenterology
10 min
expert video

UEG 2025 | Current and Emerging Treatment Options in EoE

UEG 2025 | Understanding Type 2 Inflammation in EoE: A Case-Based Discussion
Gastroenterology
34 min
expert video

UEG 2025 | Understanding Type 2 Inflammation in EoE: A Case-Based Discussion

Demystifying CPUO: Diagnosis and the Role of Type 2 Inflammation
Dermatology
6 min
expert video

Demystifying CPUO: Diagnosis and the Role of Type 2 Inflammation

How FeNO Measurement Can Improve Severe Asthma Management — Presented in Spanish by Dr. Miguel Lanz
Pulmonology
7 min
expert video

How FeNO Measurement Can Improve Severe Asthma Management — Presented in Spanish by Dr. Miguel Lanz

Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease Burden
Dermatology
10 min
expert video

Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease Burden

Airway Hyperresponsiveness In Asthma Is Mainly Driven By  Components Of Type 2 Inflammation
Pulmonology
5 min
interactivity

Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation

UEG 2025 | Bridging the Gap in EoE: Strategies for Seamless Transition of Care
Gastroenterology
45 min
expert video

UEG 2025 | Bridging the Gap in EoE: Strategies for Seamless Transition of Care

    1
    ...
    345
    ...
    25